Ayan et al. reported that the activities of both PON1 and ARES were decreased in diabetic patients, with a more pronounced reduction observed in those with incipient DN compared to diabetic patients without nephropathy [18]. This evidence concerns the gene PON1 and liver dysplastic nodule.